Accelerated FDA approval for dostarlimab in biomarker-defined locally advanced rectal cancer
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
A large SEER database analysis presented at the American College of Surgeons Clinical Congress 2026 shows that patients aged 45 ...
A prospective study of 464 rectal cancer patients in China identifies three distinct twelve-month trajectories of bowel symptoms after sphincter-preserving ...
A head-to-head study of 81 rectal cancer patients finds MRI leads for local T staging while ⁶⁸Ga-FAPI-04 PET/CT excels at ...
An exploratory analysis of a randomized trial in locally advanced rectal cancer found that an IL1B gene variant was linked ...
A multicenter Japanese propensity score-matched analysis of 294 rectal cancer patients found that neoadjuvant therapy before transanal total mesorectal excision ...
Chinese researchers have fully sequenced a rare blaNDM-5-producing, multidrug-resistant monophasic Salmonella Typhimurium ST34 strain from a rectal cancer patient in ...
A computational study identified fibroblast activation protein as the top stromal target in rectal cancer and designed a peptide inhibitor ...
A new systematic review and meta-analysis finds that adherence to colorectal cancer clinical practice guidelines is linked to significant survival ...
A nine-time-point longitudinal study tracked gut microbial species and fecal metabolites in rectal cancer patients throughout capecitabine-based chemoradiotherapy, revealing significant ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine